Pneumonia Vaccine Market
1 Introduction to Research & Analysis Reports
1.1 Pneumonia Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumonia Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumonia Vaccine Overall Market Size
2.1 Global Pneumonia Vaccine Market Size: 2021 VS 2028
2.2 Global Pneumonia Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pneumonia Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Pneumonia Vaccine Players in Global Market
3.2 Top Global Pneumonia Vaccine Companies Ranked by Revenue
3.3 Global Pneumonia Vaccine Revenue by Companies
3.4 Global Pneumonia Vaccine Sales by Companies
3.5 Global Pneumonia Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pneumonia Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pneumonia Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumonia Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pneumonia Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pneumonia Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pneumonia Vaccine Market Size Markets, 2021 & 2028
4.1.2 Pneumococcal Conjugate Vaccine (PCV13)
4.1.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
4.1.4 Other
4.2 By Type - Global Pneumonia Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pneumonia Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pneumonia Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pneumonia Vaccine Sales & Forecasts
4.3.1 By Type - Global Pneumonia Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pneumonia Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pneumonia Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pneumonia Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pneumonia Vaccine Market Size, 2021 & 2028
5.1.2 Pneumonia
5.1.3 Meningitis
5.1.4 Sepsis
5.2 By Application - Global Pneumonia Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pneumonia Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pneumonia Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pneumonia Vaccine Sales & Forecasts
5.3.1 By Application - Global Pneumonia Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pneumonia Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pneumonia Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pneumonia Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pneumonia Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pneumonia Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pneumonia Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pneumonia Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pneumonia Vaccine Sales & Forecasts
6.3.1 By Region - Global Pneumonia Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pneumonia Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pneumonia Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pneumonia Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pneumonia Vaccine Sales, 2017-2028
6.4.3 US Pneumonia Vaccine Market Size, 2017-2028
6.4.4 Canada Pneumonia Vaccine Market Size, 2017-2028
6.4.5 Mexico Pneumonia Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pneumonia Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pneumonia Vaccine Sales, 2017-2028
6.5.3 Germany Pneumonia Vaccine Market Size, 2017-2028
6.5.4 France Pneumonia Vaccine Market Size, 2017-2028
6.5.5 U.K. Pneumonia Vaccine Market Size, 2017-2028
6.5.6 Italy Pneumonia Vaccine Market Size, 2017-2028
6.5.7 Russia Pneumonia Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pneumonia Vaccine Market Size, 2017-2028
6.5.9 Benelux Pneumonia Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pneumonia Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pneumonia Vaccine Sales, 2017-2028
6.6.3 China Pneumonia Vaccine Market Size, 2017-2028
6.6.4 Japan Pneumonia Vaccine Market Size, 2017-2028
6.6.5 South Korea Pneumonia Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pneumonia Vaccine Market Size, 2017-2028
6.6.7 India Pneumonia Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pneumonia Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pneumonia Vaccine Sales, 2017-2028
6.7.3 Brazil Pneumonia Vaccine Market Size, 2017-2028
6.7.4 Argentina Pneumonia Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pneumonia Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pneumonia Vaccine Sales, 2017-2028
6.8.3 Turkey Pneumonia Vaccine Market Size, 2017-2028
6.8.4 Israel Pneumonia Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pneumonia Vaccine Market Size, 2017-2028
6.8.6 UAE Pneumonia Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Pneumonia Vaccine Major Product Offerings
7.1.4 Pfizer Inc. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Inc. Key News
7.2 Glaxosmithkline Plc.
7.2.1 Glaxosmithkline Plc. Corporate Summary
7.2.2 Glaxosmithkline Plc. Business Overview
7.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Major Product Offerings
7.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Glaxosmithkline Plc. Key News
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporate Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Pneumonia Vaccine Major Product Offerings
7.3.4 Merck & Co., Inc. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co., Inc. Key News
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Corporate Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Pneumonia Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Pasteur Key News
7.5 Serum Institute of India Pvt. Ltd.
7.5.1 Serum Institute of India Pvt. Ltd. Corporate Summary
7.5.2 Serum Institute of India Pvt. Ltd. Business Overview
7.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Major Product Offerings
7.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Serum Institute of India Pvt. Ltd. Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Pneumonia Vaccine Major Product Offerings
7.6.4 Johnson & Johnson Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Corporate Summary
7.7.2 Astellas Pharma Inc. Business Overview
7.7.3 Astellas Pharma Inc. Pneumonia Vaccine Major Product Offerings
7.7.4 Astellas Pharma Inc. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma Inc. Key News
7.8 Astrazeneca Plc.
7.8.1 Astrazeneca Plc. Corporate Summary
7.8.2 Astrazeneca Plc. Business Overview
7.8.3 Astrazeneca Plc. Pneumonia Vaccine Major Product Offerings
7.8.4 Astrazeneca Plc. Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Astrazeneca Plc. Key News
7.9 CSL Limited
7.9.1 CSL Limited Corporate Summary
7.9.2 CSL Limited Business Overview
7.9.3 CSL Limited Pneumonia Vaccine Major Product Offerings
7.9.4 CSL Limited Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 CSL Limited Key News
7.10 Emergent Biosolutions
7.10.1 Emergent Biosolutions Corporate Summary
7.10.2 Emergent Biosolutions Business Overview
7.10.3 Emergent Biosolutions Pneumonia Vaccine Major Product Offerings
7.10.4 Emergent Biosolutions Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Emergent Biosolutions Key News
7.11 Walvax Biotechnology
7.11.1 Walvax Biotechnology Corporate Summary
7.11.2 Walvax Biotechnology Pneumonia Vaccine Business Overview
7.11.3 Walvax Biotechnology Pneumonia Vaccine Major Product Offerings
7.11.4 Walvax Biotechnology Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Walvax Biotechnology Key News
7.12 Royal (Wuxi) Bio-Pharmaceutical
7.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
7.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Business Overview
7.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Major Product Offerings
7.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Royal (Wuxi) Bio-Pharmaceutical Key News
7.13 Zhifei Biologic
7.13.1 Zhifei Biologic Corporate Summary
7.13.2 Zhifei Biologic Pneumonia Vaccine Business Overview
7.13.3 Zhifei Biologic Pneumonia Vaccine Major Product Offerings
7.13.4 Zhifei Biologic Pneumonia Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Zhifei Biologic Key News
8 Global Pneumonia Vaccine Production Capacity, Analysis
8.1 Global Pneumonia Vaccine Production Capacity, 2017-2028
8.2 Pneumonia Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumonia Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pneumonia Vaccine Supply Chain Analysis
10.1 Pneumonia Vaccine Industry Value Chain
10.2 Pneumonia Vaccine Upstream Market
10.3 Pneumonia Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pneumonia Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pneumonia Vaccine in Global Market
Table 2. Top Pneumonia Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pneumonia Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pneumonia Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pneumonia Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Pneumonia Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pneumonia Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Pneumonia Vaccine Product Type
Table 9. List of Global Tier 1 Pneumonia Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumonia Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pneumonia Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pneumonia Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pneumonia Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pneumonia Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Pneumonia Vaccine Sales (K Doses), 2023-2028
Table 16. By Application ? Global Pneumonia Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pneumonia Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pneumonia Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pneumonia Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Pneumonia Vaccine Sales (K Doses), 2023-2028
Table 21. By Region ? Global Pneumonia Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pneumonia Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pneumonia Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pneumonia Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Pneumonia Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Pneumonia Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pneumonia Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pneumonia Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Pneumonia Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Pneumonia Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pneumonia Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pneumonia Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Pneumonia Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Pneumonia Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pneumonia Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pneumonia Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Pneumonia Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Pneumonia Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pneumonia Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pneumonia Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Pneumonia Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Pneumonia Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pneumonia Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pneumonia Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Pneumonia Vaccine Sales, (K Doses), 2023-2028
Table 46. Pfizer Inc. Corporate Summary
Table 47. Pfizer Inc. Pneumonia Vaccine Product Offerings
Table 48. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Glaxosmithkline Plc. Corporate Summary
Table 50. Glaxosmithkline Plc. Pneumonia Vaccine Product Offerings
Table 51. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Merck & Co., Inc. Corporate Summary
Table 53. Merck & Co., Inc. Pneumonia Vaccine Product Offerings
Table 54. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Sanofi Pasteur Corporate Summary
Table 56. Sanofi Pasteur Pneumonia Vaccine Product Offerings
Table 57. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Serum Institute of India Pvt. Ltd. Corporate Summary
Table 59. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Offerings
Table 60. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Pneumonia Vaccine Product Offerings
Table 63. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Astellas Pharma Inc. Corporate Summary
Table 65. Astellas Pharma Inc. Pneumonia Vaccine Product Offerings
Table 66. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Astrazeneca Plc. Corporate Summary
Table 68. Astrazeneca Plc. Pneumonia Vaccine Product Offerings
Table 69. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. CSL Limited Corporate Summary
Table 71. CSL Limited Pneumonia Vaccine Product Offerings
Table 72. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Emergent Biosolutions Corporate Summary
Table 74. Emergent Biosolutions Pneumonia Vaccine Product Offerings
Table 75. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Walvax Biotechnology Corporate Summary
Table 77. Walvax Biotechnology Pneumonia Vaccine Product Offerings
Table 78. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
Table 80. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Offerings
Table 81. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Zhifei Biologic Corporate Summary
Table 83. Zhifei Biologic Pneumonia Vaccine Product Offerings
Table 84. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 85. Pneumonia Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 86. Global Pneumonia Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Pneumonia Vaccine Production by Region, 2017-2022 (K Doses)
Table 88. Global Pneumonia Vaccine Production by Region, 2023-2028 (K Doses)
Table 89. Pneumonia Vaccine Market Opportunities & Trends in Global Market
Table 90. Pneumonia Vaccine Market Drivers in Global Market
Table 91. Pneumonia Vaccine Market Restraints in Global Market
Table 92. Pneumonia Vaccine Raw Materials
Table 93. Pneumonia Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Pneumonia Vaccine Downstream
Table 95. Pneumonia Vaccine Downstream Clients in Global Market
Table 96. Pneumonia Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pneumonia Vaccine Segment by Type
Figure 2. Pneumonia Vaccine Segment by Application
Figure 3. Global Pneumonia Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pneumonia Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumonia Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pneumonia Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pneumonia Vaccine Revenue in 2021
Figure 9. By Type - Global Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pneumonia Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pneumonia Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 19. US Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 33. China Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pneumonia Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pneumonia Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pneumonia Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pneumonia Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Pneumonia Vaccine by Region, 2020 VS 2027
Figure 50. Pneumonia Vaccine Industry Value Chain
Figure 51. Marketing Channels